Fetal Distribution of 5α-Reductase 1 and 5α-Reductase 2, and Their Input on Human Prostate Development

Journal of Urology

Volumn 178, Issue 2, 2007, Pages 716-721

  Lunacek, A ^c   Schwentner, C ^a   Oswald, J ^a   Fritsch, H ^a   Sergi, C ^b   Thomas, L N ^d   Rittmaster, R S ^d   Klocker, H ^a   Neuwirt, H ^a   Bartsch, G ^a   Radmayr, C ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^c Dalhousie University ^*  (Austria)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

cholestenone 5 alpha reductase; fetal development; isoenzymes; prostate

Indexed keywords

5ALPHA REDUCTASE 1; 5ALPHA REDUCTASE 2; ENZYME ANTIBODY; ISOENZYME; STEROID 5ALPHA REDUCTASE; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE 2; TESTOSTERONE 17BETA DEHYDROGENASE 3; TESTOSTERONE 17BETA DEHYDROGENASE 7; UNCLASSIFIED DRUG; CHOLESTENONE 5ALPHA REDUCTASE; HYDROXYSTEROID DEHYDROGENASE;

ANDROGEN SYNTHESIS; ARTICLE; CONTROLLED STUDY; FETUS; FETUS DEVELOPMENT; GENETIC TRANSCRIPTION; GONAD DEVELOPMENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANCY; INFANT; MALE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE DISTRIBUTION; ENZYME IMMUNOASSAY; FEMALE; GENETICS; GESTATIONAL AGE; GROWTH, DEVELOPMENT AND AGING; NEWBORN; PREGNANCY; PRENATAL DEVELOPMENT; PROSTATE;

17-HYDROXYSTEROID DEHYDROGENASES; CHOLESTENONE 5 ALPHA-REDUCTASE; FEMALE; GESTATIONAL AGE; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT, NEWBORN; ISOENZYMES; MALE; PREGNANCY; PROSTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 34447101820     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2007.03.089     Document Type: Article

References (20)

1. Isaacs J.T. Testosterone and the Prostate. 3rd ed. (2004), Cambridge University Press, Cambridge, United Kingdom 347-374
2. Kim K.S., Liu W., Cunha G.R., Russel D.W., Huang H., Shapiro E., et al. Expression of the androgen receptor and 5alpha reductase type 2 in the developing human fetal penis and urethra. Cell Tissue Res 307 (2002) 145
3. Cunha G.R., Ricke W., Thomson A., Marker P.C., Risbridger G., Hayward S.W., et al. Hormonal, cellular, and regulation of normal and neoplastic prostatic development. J Steroid Biochem Mol Biol 92 (2004) 221
4. Thomas L.N., Lazier C.B., Gupta R., Norman R.W., Troyer D.A., O'Brian S.P., et al. Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer. Prostate 231 (2005) 63
5. Schwentner C., Oswald J., Lunacek A., Fritsch H., Deibl M., Bartsch G., et al. Loss of interstitial cells of Cajal and gap junction protein connexin 43 at the vesicoureteral junction in children with vesicoureteral reflux. J Urol 174 (2005) 1981
6. Thomas L.N., Douglas R.C., Vessey J.P., Gupta R., Fontaine D., Norman R.W., et al. 5a Reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium. J Urol 170 (2003) 2019
7. Steers W.D. 5 Alpha reductase activity in the prostate. Urology 58 (2001) 17
8. Thigpen A.E., Silver R.I., Guileyardo J.M., Casey L., McConnell, and Russell D.W. Tissue distribution and ontogeny of steroid 5α-reductase isoenzyme expression. J Clin Invest 92 (1993) 903
9. Berman D.M., Tian H., and Russell D.W. Expression and regulation of steroid 5 alpha-reductase in the urogenital tract of the fetal rat. Mol Endocrinol 9 (1995) 1561
10. Wilson J.D., Leihy M.W., Shaw G., and Renfree M.B. Androgen physiology: unsolved problems at the millennium. Mol Cell Endocrinol 198 (2002) 1
11. Auchus R. The backdoor-pathway to dihydrotestosterone. Trends Endocrinol Metab 15 (2004) 432
12. Lunacek A., Oswald J., Schwentner C., Schlenck B., Horninger W., Fritsch H., et al. Growth curves of the fetal prostate based on three-dimensional reconstructions: a correlation with gestational age and maternal testosterone levels. BJU Int 99 (2007) 2212
13. Bartsch G., Rittmaster R., and Klocker H. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia. World J Urol 19 (2002) 413
14. Luu-The V. Analysis and characteristics of multiple types of human 17 β-hydroxysteroid dehydrogenase. J Steroid Biochem Mol Biol 76 (2001) 143
15. Aumüller G., Eicheler W., Renneberg H., Adermann K., Vilja P., and Forssmann W.G. Immunocytochemical evidence for differential subcellular localization of 5 alpha reductase isoenzymes in human tissues. Acta Anat 156 (1996) 241
16. Bruchovsky N., Sadar M.D., Akakura K., Goldenberg S.L., Matsuoka K., and Rennie P.S. Characterization of 5-alpha reductase gene expression in stroma and epithelium of the human prostate. J Steroid Biochem 59 (1996) 397
17. Andersson S., Berman D.M., Jenkins E.P., and Russel D.W. Deletion of steroid 5 alpha-reductase 2 gene in male pseudohermaphroditism. Nature 354 (1991) 159
18. Imperato-McGinley J., and Zhu Y.S. Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Mol Cell Endocrinol 198 (2002) 51
19. Thompson I.M., Goodman P.J., Tangen C.M., Lucia M.S., Miller G.J., Ford L.G., et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 349 (2003) 215
20. Prins G.S., Birch L., Couse J.F., Choi I., Katzenellenbogen B., and Korach K.S. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alpha-ERKO and beta-ERKO mice. Cancer Res 61 (2001) 6089